论文部分内容阅读
目的:分析评价老年高血压患者糖耐量试验的临床应用价值。方法:选取本院2015年1月-2015年12月间收治的老年高血压患者200例作为研究对象,并选择同期接受体检的非高血压、非肥胖老年志愿者作为对照,分别对其实施糖耐量试验,统计各组血糖正常(NGR)、空腹糖耐量受损(IFG)、糖耐量受损(IGT)和糖尿病(DM)患者的数量,并比较其空腹血糖(FPG)、餐后血糖(2 h PG)的检测结果,同时对不同血压分级高血压患者的糖耐量异常率进行比较。结果:老年高血压组患者中IGT和DM的比例显著高于对照组志愿者,而NGR和IFG的比例显著低于对照组志愿者,差异具有统计学意义(P<0.05)。按照高血压患者的血压水平不同进行分级,1级、2级、3级患者分别有91例、68例和41例,随着血压分级的升高,糖代谢异常率也相应升高,差异具有统计学意义(P<0.05)。其中,1级高血压患者的糖代谢异常率与对照组志愿者比较,差异无统计学意义(P>0.05)。结论:通过对老年高血压患者进行糖耐量试验,有利于及早发现糖耐量受损的情况,并给予积极的血糖控制,降低心血管疾病发生的风险。
Objective: To analyze and evaluate the clinical value of glucose tolerance test in elderly patients with hypertension. Methods: A total of 200 elderly hypertensive patients admitted from January 2015 to December 2015 in our hospital were selected as the study subjects, and non-hypertensive and non-obese elderly volunteers who were undergoing physical examinations during the same period were selected as controls. Tolerance test, the number of patients with normal glucose tolerance (NGR), impaired fasting glucose tolerance (IGT), impaired glucose tolerance (IGT) and diabetes mellitus (DM) 2 h PG) test results, at the same time, different blood pressure grading patients with impaired glucose tolerance were compared. Results: The proportion of IGT and DM in elderly patients with hypertension was significantly higher than that of volunteers in the control group, while the proportion of NGR and IFG was significantly lower than that of the volunteers in the control group (P <0.05). According to the different levels of blood pressure in patients with hypertension, there were 91 cases, 68 cases and 41 cases in grade 1, 2 and 3 respectively. With the increase of blood pressure, the rate of abnormal glucose metabolism also increased Statistical significance (P <0.05). Among them, the rate of abnormal glucose metabolism in patients with grade 1 hypertension was not significantly different from that of volunteers in the control group (P> 0.05). Conclusion: The glucose tolerance test in senile patients with hypertension is beneficial to early detection of impaired glucose tolerance and positive glycemic control to reduce the risk of cardiovascular disease.